RAC 2.86% $1.44 race oncology ltd

Ann: RC220 Toxicology and Safety Pharmacology Studies Initiated, page-21

  1. 19,103 Posts.
    lightbulb Created with Sketch. 5937
    I assume you are not down more than $50 million on your investment in RAC like me. The whole sector is in the dumps at the moment - an outcome not too many people predicted a few years ago.

    The positive news is RAC is fundamentally a much more valuable company today than it was 3 years ago. A lot has been accomplished over in this time that creates real value for shareholders.

    The example of DXB today shows how quickly sentiment can turn.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.